Mereo BioPharma Group plc (MREO)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch MREO
See up to 3 months of MREO. The 7-day demo opens the 1M and 3M ranges and puts MREO on your watchlist.
Start 7-day demoLatest MREO insider trades
About Mereo BioPharma Group plc (MREO)
Mereo BioPharma Group plc is an SEC registrant, filing under CIK 0001719714, classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
MREO Form 4 activity by transaction type, last 90 days
No Form 4 activity for MREO in the last 90 days.
MREO insider transactions (Form 4)
2913 Form 4 filings on record, the earliest from Feb 2, 2026, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Pierre Jacquet | Grant or award | Share Options (Right to buy) | 66,000 | $0.00 | - | |
| Pierre Jacquet | Grant or award | Deferred Restricted Stock Units | 106,848 | - footnote F3 | - | |
| ||||||
| Marc J. Yoskowitz | Grant or award | Share Options (Right to buy) | 66,000 | $0.00 | - | |
| Marc J. Yoskowitz | Grant or award | Deferred Restricted Stock Units | 96,163 | - footnote F3 | - | |
| ||||||
| Daniel Shames | Grant or award | Share Options (Right to buy) | 66,000 | $0.00 | - | |
| Daniel Shames | Grant or award | Deferred Restricted Stock Units | 96,163 | - footnote F3 | - | |
| ||||||
 Anders Ekblom | Grant or award | Share Options (Right to buy) | 66,000 | $0.00 | - | |
| Anders Ekblom | Grant or award | Deferred Restricted Stock Units | 133,560 | - footnote F3 | - | |
| ||||||
 Jeremy Bender | Grant or award | Share Options (Right to buy) | 66,000 | $0.00 | - | |
| Jeremy Bender | Grant or award | Deferred Restricted Stock Units | 117,533 | - footnote F3 | - | |
| ||||||
| Deepika Pakianathan | Grant or award | Share Options (Right to buy) | 66,000 | $0.00 | - | |
| Annalisa Jenkins | Grant or award | Share Options (Right to buy) | 66,000 | $0.00 | - | |
| Annalisa Jenkins | Grant or award | Deferred Restricted Stock Units | 106,848 | - footnote F3 | - | |
| ||||||
| Michael S. Wyzga | Grant or award | Share Options (Right to buy) | 66,000 | $0.00 | - | |
| John A. Lewicki - Officer | Grant or award | Share Options (Right to buy) | 139,913 | $0.00 | - | |
| John A. Lewicki - Officer | Grant or award | Share Options (Right to buy) | 46,637 | $0.00 | - | |
| John A. Lewicki - Officer | Grant or award | Share Options (Right to buy) | 145,000 | $0.00 | - | |
| Alexandra Hughes-Wilson - Officer | Grant or award | Share Options (Right to buy) | 183,750 | $0.00 | - | |
| Alexandra Hughes-Wilson - Officer | Grant or award | Share Options (Right to buy) | 61,250 | $0.00 | - | |
| Alexandra Hughes-Wilson - Officer | Grant or award | Share Options (Right to buy) | 195,000 | $0.00 | - | |
| Charles Sermon - Officer | Grant or award | Share Options (Right to buy) | 315,750 | $0.00 | - | |
| Charles Sermon - Officer | Grant or award | Share Options (Right to buy) | 105,250 | $0.00 | - | |
| Charles Sermon - Officer | Grant or award | Share Options (Right to buy) | 295,000 | $0.00 | - | |
| Denise Scots-Knight - Officer | Grant or award | Share Options (Right to buy) | 1,035,000 | $0.00 | - | |
| Denise Scots-Knight - Officer | Grant or award | Share Options (Right to buy) | 345,000 | $0.00 | - | |
| Denise Scots-Knight - Officer | Grant or award | Share Options (Right to buy) | 480,000 | $0.00 | - | |
| Christine Ann Fox - Officer | Grant or award | Share Options (Right to buy) | 315,750 | $0.00 | - | |
| Christine Ann Fox - Officer | Grant or award | Share Options (Right to buy) | 105,250 | $0.00 | - | |
| Christine Ann Fox - Officer | Grant or award | Share Options (Right to buy) | 280,000 | $0.00 | - | |
Item 3.01
Item 2.02, 9.01
Item 1.01, 7.01, 9.01
Item 5.07, 9.01
MREO insider trading FAQ
What is the latest insider trade for MREO?
Mereo BioPharma Group plc (MREO) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-02-27. The full record for MREO runs to 13 Form 4 filings, the earliest from 2026-02-02. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying MREO stock?
No insider purchases of MREO were filed in the last 90 days.
How many insiders are selling MREO stock?
No insider sales of MREO were filed in the last 90 days.
Where can I see MREO SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects MREO Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Pierre Jacquet view on EDGAR
- - Marc J. Yoskowitz view on EDGAR
- - Daniel Shames view on EDGAR
- - Anders Ekblom view on EDGAR
- - Jeremy Bender view on EDGAR
- - Deepika Pakianathan view on EDGAR
- - Annalisa Jenkins view on EDGAR
- - Michael S. Wyzga view on EDGAR
- - John A. Lewicki view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where MREO's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow MREO with a 7-day demo
- MREO on your watchlist
- Every MREO Form 4 filing on record
- Up to 3 months of MREO price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
